Medical Treatment of Hypertension in Patients with Heart Failure with Preserved Ejection Fraction

被引：2

作者：

Kiel, Richard G. ^{[1
]}

Deedwania, Prakash ^{[1
]}

机构：

[1] UCSF Fresno Med Educ Program, Vet Affairs Cent Calif Hlth Care Syst, Fresno, CA 93703 USA

来源：

CURRENT CARDIOLOGY REPORTS | 2013年 / 15卷 / 12期

关键词：

Hypertension; Heart failure with preserved ejection fraction; HF-PEF; Diastolic heart failure; Medical treatment; LEFT-VENTRICULAR HYPERTROPHY; LIPID-LOWERING TREATMENT; END-POINT REDUCTION; LOSARTAN INTERVENTION; RANDOMIZED-TRIAL; REGRESSION; MORTALITY; VERAPAMIL; TERM;

D O I：

10.1007/s11886-013-0428-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure with preserved ejection fraction (HFPEF) has become an increasingly common problem, accounting for as many as half of all diagnoses of heart failure. Hypertension has been shown to be a major risk factor for the development of HPEF, and the treatment of hypertension is key to both preventing the development of HFPEF as well as mitigating its impact on our health care system. While numerous studies have looked at using various classes of antihypertensive medications to treat HFPEF, there are still no well validated treatment strategies which have shown a significant mortality benefit. As a result, when choosing an antihypertensive medication to treat or prevent HFPEF, it is important to tailor the choice of antihypertensive medication to an individual patient's specific symptoms and comorbidities.

引用

页数：5

共 18 条

[1] VERAPAMIL-INDUCED IMPROVEMENT IN LEFT-VENTRICULAR DIASTOLIC FILLING AND INCREASED EXERCISE TOLERANCE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - SHORT-TERM AND LONG-TERM EFFECTS [J].

BONOW, RO ;

DILSIZIAN, V ;

ROSING, DR ;

MARON, BJ ;

BACHARACH, SL ;

GREEN, MV .

CIRCULATION, 1985, 72 (04) :853-864

[2] Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance [J].

Burns, Joanna ;

Ball, Stephen G. ;

Worthy, Gillian ;

Struthers, Allan D. ;

Mary, David A. S. G. ;

Greenwood, John P. .

JOURNAL OF HYPERTENSION, 2012, 30 (10) :2039-2046

[3] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[4] Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [J].

Davis, Barry R. ;

Kostis, John B. ;

Simpson, Lara M. ;

Black, Henry R. ;

Cushman, William C. ;

Einhorn, Paula T. ;

Farber, Michael A. ;

Ford, Charles E. ;

Levy, Daniel ;

Massie, Barry M. ;

Nawaz, Shah .

CIRCULATION, 2008, 118 (22) :2259-2267

[5] Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial [J].

Edelmann, Frank ;

Wachter, Rolf ;

Schmidt, Albrecht G. ;

Kraigher-Krainer, Elisabeth ;

Colantonio, Caterina ;

Kamke, Wolfram ;

Duvinage, Andre ;

Stahrenberg, Raoul ;

Durstewitz, Kathleen ;

Loeffler, Markus ;

Duengen, Hans-Dirk ;

Tschoepe, Carsten ;

Herrmann-Lingen, Christoph ;

Halle, Martin ;

Hasenfuss, Gerd ;

Gelbrich, Goetz ;

Pieske, Burkert .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08) :781-791

[6]

Faris R, 2012, COCHRANE DB SYST REV, V2

[7] FASTTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) [J].

Flather, MD ;

Shibata, MC ;

Coats, AJS ;

Van Veldhuisen, DJ ;

Parkhomenko, A ;

Borbola, J ;

Cohen-Solal, A ;

Dumitrascu, D ;

Ferrari, R ;

Lechat, P ;

Soler-Soler, J ;

Tavazzi, L ;

Spinarova, L ;

Toman, J ;

Böhm, M ;

Anker, SD ;

Thompson, SG ;

Poole-Wilson, PA .

EUROPEAN HEART JOURNAL, 2005, 26 (03) :215-225

[8] Clinical Effectiveness of Beta-Blockers in Heart Failure Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry [J].

Hernandez, Adrian F. ;

Hammill, Bradley G. ;

O'Connor, Christopher M. ;

Schulman, Kevin A. ;

Curtis, Lesley H. ;

Fonarow, Gregg C. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (02) :184-192

[9] A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension [J].

Klingbeil, AU ;

Schneider, M ;

Martus, P ;

Messerli, FH ;

Schmieder, RE .

AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01) :41-46

[10] Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association [J].

Lloyd-Jones, Donald ;

Adams, Robert J. ;

Brown, Todd M. ;

Carnethon, Mercedes ;

Dai, Shifan ;

De Simone, Giovanni ;

Ferguson, T. Bruce ;

Ford, Earl ;

Furie, Karen ;

Gillespie, Cathleen ;

Go, Alan ;

Greenlund, Kurt ;

Haase, Nancy ;

Hailpern, Susan ;

Ho, P. Michael ;

Howard, Virginia ;

Kissela, Brett ;

Kittner, Steven ;

Lackland, Daniel ;

Lisabeth, Lynda ;

Marelli, Ariane ;

McDermott, Mary M. ;

Meigs, James ;

Mozaffarian, Dariush ;

Mussolino, Michael ;

Nichol, Graham ;

Roger, Veronique L. ;

Rosamond, Wayne ;

Sacco, Ralph ;

Sorlie, Paul ;

Stafford, Randall ;

Thom, Thomas ;

Wasserthiel-Smoller, Sylvia ;

Wong, Nathan D. ;

Wylie-Rosett, Judith .

CIRCULATION, 2010, 121 (07) :E46-E215

← 1 2 →